🇺🇸 FDA
Patent

US 10017734

Method for producing dopaminergic neurons

granted A61KA61K35/30A61P

Quick answer

US patent 10017734 (Method for producing dopaminergic neurons) held by Takeda Pharmaceutical Company Limited expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/30, A61P, A61P25/00, A61P25/08